Combining ReACp53 with Carboplatin to Target High-Grade Serous Ovarian Cancers is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Cancer Society
Grant: RSG-14-217-01-TBG
Department of Veterans Affairs
Grant: I01BX004651
National Institutes of Health
Grant: U54-CA-143931
NCI NIH HHS
Grant: P50 CA211015
NCI NIH HHS
Grant: P30 CA016042
NCI NIH HHS
Grant: U54 CA143930
National Institutes of Health
Grant: 5I01BX004651-02
Reactivating p53 Function with a Novel Structure-based Peptide as a Therapeutic Approach for Overcoming Platinum Resistance
National Institutes of Health
Grant: 3U54CA143930-05S1
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
FWCI
1.22
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals